EXHIBITION PREVIEW Mast Group.
Launch Diagnostics.
Launch Diagnostics Launch Diagnostics is a leading distributor of in-vitro diagnostic (IVD) solutions, including microbiology, virology, and molecular diagnostics for the UK diagnostic laboratory market. Launch was established in 1990 and is now part of the Palex group, the leading provider of value-added medical technology solutions in Europe. The company provides high-quality
diagnostic reagents and instrumentation to support accurate and timely diagnostics, offering a diverse portfolio which includes molecular PCR assays and third-party QC, lateral flow, CLIA and ELISA tests for viral and bacterial pathogens, and an extensive range of antimicrobial-resistance testing solutions. Launch partners with globally
recognised IVD manufacturers to bring the latest innovations to UK laboratories, ensuring access to high- performance diagnostic tools. It also offers comprehensive technical support and training, helping laboratories upskill
staff, enhance efficiency and maintain the highest standards. With decades of expertise and a
commitment to innovation, Launch continues to play a pivotal role in strengthening the UK’s diagnostic capabilities in microbiology, virology, and molecular testing, supporting the fight against infectious diseases and antimicrobial resistance.
www.launchdiagnostics.com
Mast Group Mast Group is a world-class manufacturer and global supplier of diagnostic products. As an independent company, since 1959, its commitment to maintaining integrity and customer satisfaction, combined with innovation in in vitro diagnostics, has resulted in improved clinical decisions and pathways. With regulatory certification to meet customer requirements and increasingly stringent medical device standards with the transition to IVDR, Mast prides itself on quality, innovation and service.
Mast Group offers its extensive product
range through its own companies plus a global network of distributors. In the UK, Mast has production facilities in Bootle near Liverpool, multiple sites in Daresbury and R&D laboratories and production facilities in Deeside. In addition there are subsidiary companies in Reinfeld, Germany; Amiens, France; and Randburg, South Africa. Mast Group is a pioneer of antibiotic
susceptibility testing (AST), and has over 65 years’ experience, supporting the AMR challenge through innovation across the portfolio. The widely established MAST URI System and more recent launch of the MAST URI Connect solution streamlines and optimises urine microbiology allowing culture, identification and AST to be reported in 95% of samples in 24 hours. Mast also offers a range of molecular diagnostic solutions and supplies the world leading solution for quantitative faecal immunochemical testing (FIT).
www.mast-group.com
April 2026
WWW.PATHOLOGYINPRACTICE.COM 47
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
